Have you considered using Raster-scan optoacoustic mesocopy (RSOM) in your dermatology clinical trial? Here are three main reasons why RSOM improves your clinical trial in dermatology drug development: #molecularmonday #RSOM #skin #melanoma #atopicdermatitis #drugdevelopment #dermatology
TRACER’s Post
More Relevant Posts
-
Learn about the latest developments in dermatology! Recent studies have been published on the unified diagnosis and definition of Generalized Pustular Psoriasis (GPP), as well as on the growing incidence of skin cancer in Gen Z compared to previous generations. For more information, references are included in the last image. #ISD #InternationalSchoolDerma #Dermatology
-
Director of Dermatopathology & Dermatologist with a great breadth of expertise contributing to advances in Dermatopathology, Immunodermatology, patient care, education, research, & healthcare policy.
Excited to be speaking at #AADInnovation2024 on "Clinching the Diagnosis: Dermpath, CPC, Testing & Beyond and Co-Directing Innovations in Dermatopathology." Join me as we explore cutting-edge advancements in the field that are reshaping how we diagnose and manage skin conditions and tumors. Looking forward to sharing insights and discussing the future of dermatopathology with fellow experts! 🌟 See you in Seattle! #Dermatology #MedicalInnovation #SkinHealth American Academy of Dermatology Northwell Health #dermatopathology #dermatology #precisionmedicine
-
-
Now published in Dermatology and Therapy: Efficacy of an IL-17A inhibitor in patients with #psoriaticarthritis, based on psoriasis severity. View the full publication here: https://e.lilly/3Vq2KIC #PsA #PsO #Dermatology
-
Dermatology is a broad, fast-moving field. From eczema to metastatic melanoma, our team of experts has the experience needed to help product developers accelerate innovation and enrich the likelihood of trial success: https://lnkd.in/eSEtb6aZ #DrugDevelopment #ClinicalResearch #Dermatology #ClinicalTrials
-
Knock out psoriasis 🥊💥 This morning at the late breaker session at the American Academy of Dermatology annual meeting, Dr. Andy Blauvelt presented results for high induction dose of risankizumab. Patients received the IL-23 inhibitor at weeks 0, 4, and 16 with no further treatment. Results showed sustained response through 52 weeks! Future of psoriasis? Check out the clip below and let us know what you think. #psoriasis #aad2024 #dermatology
-
#ICYMI: Our Chief Scientific Officer and Head of R&D, Iain Stuart discussed the potential of BET inhibitors such as VYN201 in the therapeutic landscape of #vitiligo with Dermatology Times. Watch the interview here: https://lnkd.in/e-2uA66M #VYNEinnovation #dermatology
-
-
Our experts will be at American Academy of Dermatology Annual Meeting! Stop by booth #3323 to discuss: ✅ Deep Clinical #RealWorldData ✅ #AI & #PredictiveMedicine ✅ #RealWorldEvidence and Analytics Not joining in person? Schedule a meeting with us to learn more about our #dermatology research network 📩 (info@om1.com). #AAD24
-
-
Continuing Initiate's Reimbursement Radar series, Harry Lewis reports on the reimbursement decisions made for products for dermatology and ophthalmology in Q1 and Q2 2024. If you would like to know more do get in touch and follow Initiate for more insights on reimbursement decisions across different disease areas. #ReimbursementRadar #HTA #MarketAccess #HEOR #dermatology #ophthalmology
-
-
🔎 Interesting read: "Montreal Derm FilEZ: Validation of an Online Dermatology Educational Platform for Medical Dermatology Residents, a Randomized Control Trial" 🙏 Thank you to all 47 dermatology residents across Canada who participated in this RCT. #medicaleducation #dermatology #montrealdermfilez
-
-
JAK Inhibitors for Alopecia Areata 💊 Check out this fab infographic Stacey White and I produced ahead of the launch of Dermatology, The American Medical Journal! 🇺🇸 More coming soon 👀 https://lnkd.in/eaNpZ_6F EMJ #alopecia #dermatology
-
